Correction to: ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis.

Saved in:
Bibliographic Details
Title: Correction to: ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis.
Authors: Rakhshan K; Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Sharifi M; Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.; Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran., Ramezani F; Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran., Azizi Y; Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.; Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran., Aboutaleb N; Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran. Aboutaleb.n@iums.ac.ir.; Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. Aboutaleb.n@iums.ac.ir.
Source: Molecular biology reports [Mol Biol Rep] 2023 May; Vol. 50 (5), pp. 4753-4754.
Publication Type: Published Erratum
Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Print Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first